| Literature DB >> 28778586 |
Norihito Hayatsu1, Takahisa Miyao1, Masashi Tachibana1, Ryuichi Murakami2, Akihiko Kimura1, Takako Kato1, Eiryo Kawakami3, Takaho A Endo4, Ruka Setoguchi5, Hiroshi Watarai6, Takeshi Nishikawa1, Takuwa Yasuda5, Hisahiro Yoshida5, Shohei Hori7.
Abstract
Foxp3 controls the development and function of regulatory T (Treg) cells, but it remains elusive how Foxp3 functions in vivo. Here, we established mouse models harboring three unique missense Foxp3 mutations that were identified in patients with the autoimmune disease IPEX. The I363V and R397W mutations were loss-of-function mutations, causing multi-organ inflammation by globally compromising Treg cell physiology. By contrast, the A384T mutation induced a distinctive tissue-restricted inflammation by specifically impairing the ability of Treg cells to compete with pathogenic T cells in certain non-lymphoid tissues. Mechanistically, repressed BATF expression contributed to these A384T effects. At the molecular level, the A384T mutation altered Foxp3 interactions with its specific target genes including Batf by broadening its DNA-binding specificity. Our findings identify BATF as a critical regulator of tissue Treg cells and suggest that sequence-specific perturbations of Foxp3-DNA interactions can influence specific facets of Treg cell physiology and the immunopathologies they regulate.Entities:
Keywords: BATF; DNA-binding specificity; Foxp3; autoimmunity; disease-causing mutation; non-lymphoid tissues; regulatory T cells
Mesh:
Substances:
Year: 2017 PMID: 28778586 DOI: 10.1016/j.immuni.2017.07.008
Source DB: PubMed Journal: Immunity ISSN: 1074-7613 Impact factor: 31.745